23andMe: Spit, Scandal, and a $6 Billion Meltdown with Kevin Sullivan and Laura Peek | 88
The Big Flop
00:00
The Tumultuous Journey of 23andMe
This chapter explores the significant challenges faced by 23andMe, including a drastic 30% revenue drop and shifts in customer behavior that have led to stagnant sales. It highlights cybersecurity breaches, controversial leadership decisions, and the company’s struggle to maintain its market presence amid financial turmoil and the pursuit of a new subscription model. The narrative culminates in a reflection on the complexities of entrepreneurial leadership in the biotech industry, especially relating to gender dynamics and business failures.
Transcript
Play full episode
